期刊文献+

嗅球蛋白1在肺癌组织中的表达及可能意义

Expression of OLFM1 protein in lung cancer tissue and its significance
下载PDF
导出
摘要 目的通过对比嗅球蛋白1(OLFM1)基因及其蛋白在肺癌组织及其配对的正常肺组织中的表达情况,探讨其表达与肺癌发生的相互关系。方法分别采用半定量RT-PCR法和荧光实时定量PCR检测21例肺癌患者的原位肺癌组织及其配对正常肺组织中OLFM1基因的相对表达变化和相对表达量,应用免疫组织化学染色观察OLFM1蛋白在组织中的表达。结果OLFM1基因在8例肺鳞癌原发灶中的表达相对于其配对正常组织中的表达显著下调约2.2倍(P=0.028);OLFM1蛋白定位于肺腺癌细胞胞质,仅在肺腺癌表达(P<0.001),其表达在不同年龄、性别、肿瘤分期、分化程度间差异均无统计学意义(P>0.05)。结论OLFM1基因肺鳞癌中表达下调,可能是一个潜在的分子标志;而OLFM1蛋白仅在肺腺癌表达,在肺鳞癌和正常组织中均不表达,这提示不同病理组织类型肺癌的发生可能有不同的发生机制和途径。 Objective To explore the relationship of OLFM1 expression with the development of lung cancer by comparing the OLFM1 expression in lung cancer specimens and matched normal lung specimens.Methods The OLFM1 mRNA expression was examined by semi-quantitative RT-PCR and fluorescence quantitative PCR in 21 lung cancer tissues and the paired normal lung tissues,and the protein expression of OLFM1 was detected by immunohistochemistry.Results The OLFM mRNA expression levels in 8 primary lung squamous cell carcinoma tissues were decreased by 2.2 folds compared with that in the matched normal lung tissues,with the difference being significantly different(P=0.028).The OLFM1 protein was located in cytoplasm and only expressed in lung adenocarcinoma tissues(P0.001),and the expression was not associated with patients' age,gender,tumor stage,and differentiation degrees(P0.05).Conclusion The lower expression of OLFM1 gene in lung squamous cell carcinoma may serve as a potential molecule marker for the condition.The expression of OLFM1 protein in lung adenocarcinoma,but not in lung squamous cell carcinoma and normal lung tissue,may suggest that different pathological types of lung cancers may have different pathological mechanisms.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2010年第3期269-273,共5页 Academic Journal of Second Military Medical University
基金 上海市登山计划重大课题(06DZ19503)~~
关键词 肺肿瘤 腺癌 鳞状细胞癌 OLFM基因 免疫组织化学染色 肺癌组织 蛋白表达 肺鳞癌 肺癌患者 正常组织 lung neoplasms adenocarcinoma squamous cell cancer OLFM1 gene immunohistochemistry
  • 相关文献

参考文献16

  • 1J emal A, Siegel R, Ward E, H ao Y, Xu J, Thun M J. Cancer statistics, 2009[J]. CA Cancer J Clin, 2009,59 : 225-249.
  • 2赵晋丰,吴玲玲,常文军,黄盛东,余永伟,赵立军,陈祎佳,曹广文.肺癌噬菌体展示肽库的构建及肺癌早期检测分子标志的筛选[J].第二军医大学学报,2008,29(10):1157-1161. 被引量:3
  • 3Laterza O F, Modur V R, Crimmins D L, Olander J V, Landt Y, Lee J M,et al. Identification of novel brain biomarkers[J]. Clin Chem,2006,52:1713-1721.
  • 4Barembaum M, Moreno T A, LaBonne C, Sechrist J, Bronner- Fraser M. Noelin-1 is a secreted glyeoprotein involved in generation of the neural crest[J]. Nat Cell Biol, 2000,2:219-225.
  • 5Rich J N, Hans C, Jones B, Iversen E S, McLendon R E, Rasheed B K, et al. Gene expression profiling and genetic markers in glioblastoma survival[J]. Cancer Res, 2005,65 : 4051-4058.
  • 6Evans C O,Moreno C S,Zhan X,McCabe M T,Vertino P M, Desiderio D M, et al. Molecular pathogenesis of human prolactinomas identified by gene expression profiling, RT-qPCR, and proteomic analyses[J]. Pituitary, 2008,11 : 231-245.
  • 7Allander S V, Illei P B, Chen Y, Antonescu C R, Bittner M, Ladanyi M, et al. Expression profiling of synovial sarcoma by cDNA microarrays[J]. Am J Pathol,2002,161 : 1587-1595.
  • 8Wong Y F,Cheung T H,Lo K W,Yim S F,Siu N S,Chan S C,et al. Idemification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling[J]. Oncogene,2007,26:1971-1982.
  • 9Borczuk A C,Kim H K,Yegen H A,Friedman R A,Powell C A. Lung adenocarcinoma global profiling identifies type Ⅱ TGF- receptor as a repressor of invasiveness[J].Am J Respir Crit Care Med,2005,172:729-737.
  • 10曾谊,梁杰,沈洪兵.南京市1996-2005年1128例肺癌住院病例发病特征的动态变化分析[J].中国肺癌杂志,2008,11(3):406-409. 被引量:18

二级参考文献25

  • 1项永兵,高玉堂.非吸烟女性肺癌危险因素的多分类logistic模型分析[J].中国卫生统计,2005,22(2):66-70. 被引量:30
  • 2王瑾,许峰,周清华.肺癌流行病学研究进展[J].中国肺癌杂志,2005,8(5):395-400. 被引量:59
  • 3邹小农.中国肺癌流行病学[J].中华肿瘤防治杂志,2007,14(12):881-883. 被引量:152
  • 4Parkin DM, Bary FB, Pisani P. Global cancer statistics. CA Cancer J Clin, 2005, 55(2): 74-108.
  • 5Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide, Version 2.0.IARC Cancer Base No.5.Lyon: IARC Press, 2004. 121.
  • 6Yang P, Williams B, Adjei A, et al. Characteristics of lung cancer patients who were diagnosed younger than 50 or older than 80 years of age. Lung Cancer, 2005, 49(S2): S22.
  • 7Daroeha T, Skoczylas P, Smolen A, et al. Active and passive smoking among students of Polish high schools-national survey research. Lung Cancer, 2005, 49(S2): S190.
  • 8Visser O, Belderbos J, Kwa H, et al. Improved stage-specific survival of NSCLC in Northern Holland Flevoland, The Netherl and-Effect of intensified treatment or stage migration. Lung Cancer, 2005, 49(S2):S198.
  • 9Sanchez de Cos J, Miravet L, Nunez A, et al. Lung cancer (LC) in Spain. Last epidemiological trends concerning age,gender,smoking prevalence and histological types. Lung Cancer, 2005, 49(S2): S196.
  • 10Hirsch F R,Franklin W A,Gazdar A F,Bunn P A. Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology[J]. Clin Cancer Res, 2001,7 : 5-22.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部